|
In 2021, Procter and Gamble Health focused on expanding its product portfolio in India, emphasizing health and wellness solutions tailored to local needs. The company introduced new dietary supplements and over-the-counter medications that cater to the Indian market, such as vitamin D supplements to address widespread deficiencies and immunity boosters amid the COVID-19 pandemic. These products were marketed through digital campaigns and partnerships with local healthcare providers, ensuring accessibility in both urban and rural areas. Additionally, P&G Health maintained its dividend distribution strategy in 2021, rewarding shareholders while investing in sustainable growth initiatives in India, including community health programs and eco-friendly packaging. |
